ZENTIVA GROUP REVENUES
Prized European assets up for grabs as India Inc. looks abroadIndian companies are actively pursuing acquisitions in Europe. This trend is driven by growing confidence and stronger financial positions....
Aurobindo Pharma closing in on $5.5b Zentiva buyoutLargest Indian pharma M&A in final lap; PE firm GTCR only other contender. A portfolio company of Advent International, Zentiva will signif...
Analysts slash Sanofi target over Ankleshwar plant saleThe stock ended flat at ₹5,928 on Friday.
How clerk-turned-billionaire Ramprasad Reddy made Aurobindo a giant pharma companyRamprasad Reddy has his skin the game; he has made some timely bets with a nifty strategy for Aurobindo.- Mylan buys Merck’s generics unitMylan Laboratories agreed to buy Merck KGaA’s generic-drug unit for 4.9 billion euros ($6.7 billion) in cash to become the world’s third-la...
Load More